scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.27913 |
P698 | PubMed publication ID | 25999047 |
P50 | author | Eike Steinmann | Q56333636 |
Inés Romero Brey | Q64605824 | ||
Florian Wolfgang Rudolf Vondran | Q79416184 | ||
Christine Goffinet | Q79511859 | ||
Luis María Schang | Q81095460 | ||
Patrick Behrendt | Q114416609 | ||
Paula Monteiro Perin | Q117234803 | ||
Ralf Bartenschlager | Q20664754 | ||
Markus H Heim | Q39188870 | ||
Che C Colpitts | Q42320812 | ||
Thomas Pietschmann | Q42605515 | ||
Daniel Todt | Q47137202 | ||
P2093 | author name string | Carola Berger | |
Anggakusuma | |||
Michael Engelmann | |||
Shuting Xu | |||
Tujana Boldanova | |||
P2860 | cites work | Mx proteins: GTPases with antiviral activity | Q75293405 |
The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A | Q21131379 | ||
cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism | Q22008532 | ||
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment | Q24337128 | ||
A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A | Q24632380 | ||
Regulation of hepatic innate immunity by hepatitis C virus | Q26824743 | ||
Innate and adaptive immune responses in HCV infections | Q26851685 | ||
Global epidemiology and genotype distribution of the hepatitis C virus infection | Q27001240 | ||
Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication | Q27339861 | ||
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication | Q27472912 | ||
Interferon-inducible antiviral effectors | Q27486790 | ||
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor | Q27490234 | ||
The enzymes, regulation, and genetics of bile acid synthesis | Q28204726 | ||
Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol | Q28282311 | ||
Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) | Q28730628 | ||
Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus | Q33400538 | ||
Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes | Q33855523 | ||
25-Hydroxycholesterol acts as an amplifier of inflammatory signaling | Q33972004 | ||
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus | Q34010288 | ||
Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes | Q34163327 | ||
The dependence of viral RNA replication on co-opted host factors | Q34241671 | ||
Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons | Q34378778 | ||
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation | Q34400001 | ||
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication | Q34430077 | ||
Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2. | Q34593688 | ||
Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms | Q34616709 | ||
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein | Q35252021 | ||
Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection | Q35745376 | ||
Systematic identification of type I and type II interferon-induced antiviral factors | Q35837132 | ||
The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response | Q36567141 | ||
Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. | Q36760237 | ||
25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production | Q37377292 | ||
The antiviral potentials of Mx proteins | Q37384756 | ||
Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. | Q37710976 | ||
On the formation and possible biological role of 25-hydroxycholesterol. | Q38021545 | ||
Novel therapies for hepatitis C - one pill fits all? | Q38117549 | ||
Interferon-stimulated genes and their role in controlling hepatitis C virus | Q38128136 | ||
Lipids in innate antiviral defense | Q38153910 | ||
Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside--caught in the web. | Q38195556 | ||
25-Hydroxycholesterols in innate and adaptive immunity | Q38260971 | ||
Hepatitis C virus RNA replication and assembly: living on the fat of the land | Q38294573 | ||
Mx GTPases: dynamin-like antiviral machines of innate immunity | Q38312100 | ||
Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection | Q38901568 | ||
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells | Q39117420 | ||
DNA sensing unchained | Q39192403 | ||
Cholesterol biosynthesis modulation regulates dengue viral replication | Q39856050 | ||
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics | Q40211546 | ||
Hepatitis C: the clinical spectrum of disease | Q41598735 | ||
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry | Q41844055 | ||
Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment | Q41851727 | ||
Increased serum oxysterol concentrations in patients with chronic hepatitis C virus infection. | Q42237257 | ||
All-oral HCV therapies near approval | Q42992684 | ||
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus | Q43038816 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis C virus | Q708693 |
P304 | page(s) | 702-714 | |
P577 | publication date | 2015-05-22 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation | |
P478 | volume | 62 |
Q33737534 | 17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle |
Q37530422 | 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation |
Q98564944 | 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor |
Q92904684 | 25-Hydroxycholesterol provides antiviral protection against highly pathogenic porcine reproductive and respiratory syndrome virus in swine |
Q57476231 | Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol |
Q40421264 | Antiviral Innate Immune Response Interferes with the Formation of Replication-Associated Membrane Structures Induced by a Positive-Strand RNA Virus |
Q63246525 | Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism |
Q40116058 | Cholesterol 25-Hydroxylase Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication through Enzyme Activity-Dependent and -Independent Mechanisms |
Q91447831 | Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways |
Q95836398 | Cholesterol 25-hydroxylase inhibits encephalomyocarditis virus replication through enzyme activity-dependent and independent mechanisms |
Q84315415 | Cholesterol 25-hydroxylase negatively regulates porcine intestinal coronavirus replication by the production of 25-hydroxycholesterol |
Q28353943 | Effects of Interferons and Viruses on Metabolism |
Q63246373 | Fish Cholesterol 25-Hydroxylase Inhibits Virus Replication via Regulating Interferon Immune Response or Affecting Virus Entry |
Q26779128 | Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection |
Q92879584 | Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver |
Q39327457 | Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection |
Q39366921 | Immunometabolic Signaling Pathways Contribute to Macrophage and Dendritic Cell Function. |
Q39435797 | Interaction of the innate immune system with positive-strand RNA virus replication organelles |
Q39076009 | Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection |
Q47552406 | Interferons: Reprogramming the Metabolic Network against Viral Infection |
Q92152941 | Porcine Reproductive and Respiratory Syndrome Virus E Protein Degrades Porcine Cholesterol 25-Hydroxylase via the Ubiquitin-Proteasome Pathway |
Q57072613 | Sterol Metabolism and Transport in Atherosclerosis and Cancer |
Q38969477 | The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response |
Q61820968 | The Oxysterol 25-Hydroxycholesterol Inhibits Replication of Murine Norovirus |
Q56797665 | The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo |
Q33911258 | Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. |
Search more.